Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

OXM vs GH vs RL vs EXAS vs PVH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
OXM
Oxford Industries, Inc.

Apparel - Manufacturers

Consumer CyclicalNYSE • US
Market Cap$675M
5Y Perf.+6.7%
GH
Guardant Health, Inc.

Medical - Diagnostics & Research

HealthcareNASDAQ • US
Market Cap$12.10B
5Y Perf.+5.9%
RL
Ralph Lauren Corporation

Apparel - Manufacturers

Consumer CyclicalNYSE • US
Market Cap$47.87B
5Y Perf.+374.7%
EXAS
Exact Sciences Corporation

Medical - Diagnostics & Research

HealthcareNASDAQ • US
Market Cap$20.02B
5Y Perf.+20.4%
PVH
PVH Corp.

Apparel - Manufacturers

Consumer CyclicalNYSE • US
Market Cap$4.06B
5Y Perf.+96.8%

OXM vs GH vs RL vs EXAS vs PVH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
OXM logoOXM
GH logoGH
RL logoRL
EXAS logoEXAS
PVH logoPVH
IndustryApparel - ManufacturersMedical - Diagnostics & ResearchApparel - ManufacturersMedical - Diagnostics & ResearchApparel - Manufacturers
Market Cap$675M$12.10B$47.87B$20.02B$4.06B
Revenue (TTM)$1.49B$1.08B$7.83B$3.25B$8.78B
Net Income (TTM)$-3M$-433M$919M$-208M$469M
Gross Margin61.7%64.9%69.6%69.7%58.2%
Operating Margin-0.2%-41.4%15.0%-6.4%7.4%
Forward P/E20.4x22.0x582.8x8.2x
Total Debt$449M$1.68B$2.67B$2.52B$3.39B
Cash & Equiv.$9M$378M$1.92B$956M$748M

OXM vs GH vs RL vs EXAS vs PVHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

OXM
GH
RL
EXAS
PVH
StockMay 20May 26Return
Oxford Industries, … (OXM)100106.7+6.7%
Guardant Health, In… (GH)100105.9+5.9%
Ralph Lauren Corpor… (RL)100474.7+374.7%
Exact Sciences Corp… (EXAS)100120.4+20.4%
PVH Corp. (PVH)100196.8+96.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: OXM vs GH vs RL vs EXAS vs PVH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: GH and RL are tied at the top with 2 categories each (5-stock set) — the right choice depends on your priorities. Ralph Lauren Corporation is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. OXM, EXAS, and PVH also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
OXM
Oxford Industries, Inc.
The Income Pick

OXM ranks third and is worth considering specifically for income & stability.

  • Dividend streak 4 yrs, beta 1.68, yield 6.0%
  • 6.0% yield, 4-year raise streak, vs RL's 0.9%, (2 stocks pay no dividend)
Best for: income & stability
GH
Guardant Health, Inc.
The Growth Leader

GH has the current edge in this matchup, primarily because of its strength in growth and momentum.

  • 32.9% revenue growth vs PVH's -6.1%
  • +132.2% vs OXM's -9.4%
Best for: growth and momentum
RL
Ralph Lauren Corporation
The Quality Compounder

RL is the #2 pick in this set and the best alternative if quality and efficiency is your priority.

  • 11.7% margin vs GH's -40.1%
  • 11.8% ROA vs GH's -26.5%, ROIC 20.6% vs -34.9%
Best for: quality and efficiency
EXAS
Exact Sciences Corporation
The Growth Play

EXAS is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth 17.7%, EPS growth 80.3%, 3Y rev CAGR 15.9%
  • 16.7% 10Y total return vs RL's 319.2%
  • Lower volatility, beta 0.12, current ratio 2.43x
  • Beta 0.12, current ratio 2.43x
Best for: growth exposure and long-term compounding
PVH
PVH Corp.
The Value Pick

PVH is the clearest fit if your priority is valuation efficiency.

  • PEG 0.60 vs OXM's 2.64
  • Lower P/E (8.2x vs 582.8x)
Best for: valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthGH logoGH32.9% revenue growth vs PVH's -6.1%
ValuePVH logoPVHLower P/E (8.2x vs 582.8x)
Quality / MarginsRL logoRL11.7% margin vs GH's -40.1%
Stability / SafetyEXAS logoEXASBeta 0.12 vs OXM's 1.68
DividendsOXM logoOXM6.0% yield, 4-year raise streak, vs RL's 0.9%, (2 stocks pay no dividend)
Momentum (1Y)GH logoGH+132.2% vs OXM's -9.4%
Efficiency (ROA)RL logoRL11.8% ROA vs GH's -26.5%, ROIC 20.6% vs -34.9%

OXM vs GH vs RL vs EXAS vs PVH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

OXMOxford Industries, Inc.
FY 2024
Tommy Bahama
65.8%$870M
Lilly Pulitzer
24.5%$324M
Emerging Brands
9.7%$128M
GHGuardant Health, Inc.
FY 2025
Oncology
69.6%$684M
Biopharma & Data
21.4%$210M
Screening
8.1%$80M
Licensing & Other
0.9%$9M
RLRalph Lauren Corporation
FY 2020
Other Non-Reportable Segment-Related
100.0%$370M
EXASExact Sciences Corporation
FY 2025
Screening
77.9%$2.5B
Precision Oncology
22.1%$717M
PVHPVH Corp.
FY 2024
Product
95.8%$8.2B
Royalty
4.2%$361M

OXM vs GH vs RL vs EXAS vs PVH — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLEXASLAGGINGPVH

Income & Cash Flow (Last 12 Months)

EXAS leads this category, winning 3 of 6 comparable metrics.

PVH is the larger business by revenue, generating $8.8B annually — 8.1x GH's $1.1B. RL is the more profitable business, keeping 11.7% of every revenue dollar as net income compared to GH's -40.1%. On growth, GH holds the edge at +48.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricOXM logoOXMOxford Industries…GH logoGHGuardant Health, …RL logoRLRalph Lauren Corp…EXAS logoEXASExact Sciences Co…PVH logoPVHPVH Corp.
RevenueTrailing 12 months$1.5B$1.1B$7.8B$3.2B$8.8B
EBITDAEarnings before interest/tax$64M-$418M$1.4B-$41M$924M
Net IncomeAfter-tax profit-$3M-$433M$919M-$208M$469M
Free Cash FlowCash after capex$26M-$225M$695M$357M$516M
Gross MarginGross profit ÷ Revenue+61.7%+64.9%+69.6%+69.7%+58.2%
Operating MarginEBIT ÷ Revenue-0.2%-41.4%+15.0%-6.4%+7.4%
Net MarginNet income ÷ Revenue-0.2%-40.1%+11.7%-6.4%+5.3%
FCF MarginFCF ÷ Revenue+1.7%-20.8%+8.9%+11.0%+5.9%
Rev. Growth (YoY)Latest quarter vs prior year-0.2%+48.3%+12.2%+23.1%+4.5%
EPS Growth (YoY)Latest quarter vs prior year-16.1%-10.4%+24.7%+90.4%+65.0%
EXAS leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

PVH leads this category, winning 4 of 7 comparable metrics.

At 7.7x trailing earnings, OXM trades at a 75% valuation discount to RL's 30.5x P/E. Adjusting for growth (PEG ratio), PVH offers better value at 0.62x vs RL's 1.65x — a lower PEG means you pay less per unit of expected earnings growth.

MetricOXM logoOXMOxford Industries…GH logoGHGuardant Health, …RL logoRLRalph Lauren Corp…EXAS logoEXASExact Sciences Co…PVH logoPVHPVH Corp.
Market CapShares × price$675M$12.1B$47.9B$20.0B$4.1B
Enterprise ValueMkt cap + debt − cash$1.1B$13.4B$48.6B$21.6B$6.7B
Trailing P/EPrice ÷ TTM EPS7.73x-27.79x30.45x-95.37x8.39x
Forward P/EPrice ÷ next-FY EPS est.20.37x21.98x582.83x8.20x
PEG RatioP/E ÷ EPS growth rate1.00x1.65x0.62x
EV / EBITDAEnterprise value multiple5.96x42.21x6.61x
Price / SalesMarket cap ÷ Revenue0.45x12.32x6.76x6.16x0.47x
Price / BookPrice ÷ Book value/share1.15x8.74x8.24x0.98x
Price / FCFMarket cap ÷ FCF11.29x46.98x56.10x6.97x
PVH leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

RL leads this category, winning 6 of 9 comparable metrics.

RL delivers a 31.8% return on equity — every $100 of shareholder capital generates $32 in annual profit, vs $-9 for EXAS. PVH carries lower financial leverage with a 0.66x debt-to-equity ratio, signaling a more conservative balance sheet compared to EXAS's 1.05x. On the Piotroski fundamental quality scale (0–9), RL scores 8/9 vs GH's 5/9, reflecting strong financial health.

MetricOXM logoOXMOxford Industries…GH logoGHGuardant Health, …RL logoRLRalph Lauren Corp…EXAS logoEXASExact Sciences Co…PVH logoPVHPVH Corp.
ROE (TTM)Return on equity-0.6%+31.8%-8.7%+9.6%
ROA (TTM)Return on assets-0.2%-26.5%+11.8%-3.5%+4.0%
ROICReturn on invested capital+9.1%-34.9%+20.6%-3.6%+7.0%
ROCEReturn on capital employed+12.5%-29.4%+18.6%-4.0%+8.8%
Piotroski ScoreFundamental quality 0–955877
Debt / EquityFinancial leverage0.72x1.03x1.05x0.66x
Net DebtTotal debt minus cash$440M$1.3B$746M$1.6B$2.6B
Cash & Equiv.Liquid assets$9M$378M$1.9B$956M$748M
Total DebtShort + long-term debt$449M$1.7B$2.7B$2.5B$3.4B
Interest CoverageEBIT ÷ Interest expense-0.55x-181.67x23.25x-5.47x2.42x
RL leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

GH leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in RL five years ago would be worth $26,443 today (with dividends reinvested), compared to $6,073 for OXM. Over the past 12 months, GH leads with a +132.2% total return vs OXM's -9.4%. The 3-year compound annual growth rate (CAGR) favors GH at 57.7% vs OXM's -20.3% — a key indicator of consistent wealth creation.

MetricOXM logoOXMOxford Industries…GH logoGHGuardant Health, …RL logoRLRalph Lauren Corp…EXAS logoEXASExact Sciences Co…PVH logoPVHPVH Corp.
YTD ReturnYear-to-date+30.3%-9.3%-2.2%+3.1%+30.7%
1-Year ReturnPast 12 months-9.4%+132.2%+48.6%+96.9%+24.6%
3-Year ReturnCumulative with dividends-49.3%+292.1%+225.3%+53.0%+7.7%
5-Year ReturnCumulative with dividends-39.3%-31.9%+164.4%+0.4%-24.8%
10-Year ReturnCumulative with dividends+2.4%+186.5%+319.2%+1669.1%-1.9%
CAGR (3Y)Annualised 3-year return-20.3%+57.7%+48.2%+15.2%+2.5%
GH leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

EXAS leads this category, winning 2 of 2 comparable metrics.

EXAS is the less volatile stock with a 0.12 beta — it tends to amplify market swings less than OXM's 1.68 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EXAS currently trades 99.9% from its 52-week high vs OXM's 75.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricOXM logoOXMOxford Industries…GH logoGHGuardant Health, …RL logoRLRalph Lauren Corp…EXAS logoEXASExact Sciences Co…PVH logoPVHPVH Corp.
Beta (5Y)Sensitivity to S&P 5001.74x0.86x1.53x0.05x1.50x
52-Week HighHighest price in past year$60.31$120.74$393.41$104.98$100.15
52-Week LowLowest price in past year$30.57$36.36$237.83$38.81$59.60
% of 52W HighCurrent price vs 52-week peak+75.2%+76.4%+89.9%+99.9%+88.5%
RSI (14)Momentum oscillator 0–10059.955.954.876.460.3
Avg Volume (50D)Average daily shares traded308K1.9M532K4.2M1.1M
EXAS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

OXM leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: OXM as "Buy", GH as "Buy", RL as "Buy", EXAS as "Buy", PVH as "Buy". Consensus price targets imply 44.3% upside for GH (target: $133) vs -23.6% for OXM (target: $35). For income investors, OXM offers the higher dividend yield at 6.02% vs PVH's 0.17%.

MetricOXM logoOXMOxford Industries…GH logoGHGuardant Health, …RL logoRLRalph Lauren Corp…EXAS logoEXASExact Sciences Co…PVH logoPVHPVH Corp.
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyBuy
Price TargetConsensus 12-month target$34.67$133.14$429.13$105.00$100.00
# AnalystsCovering analysts2130484138
Dividend YieldAnnual dividend ÷ price+6.0%+0.9%+0.2%
Dividend StreakConsecutive years of raises440
Dividend / ShareAnnual DPS$2.73$3.14$0.15
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.1%+1.0%+0.1%+12.9%
OXM leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

EXAS leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). PVH leads in 1 (Valuation Metrics).

Best OverallExact Sciences Corporation (EXAS)Leads 2 of 6 categories
Loading custom metrics...

OXM vs GH vs RL vs EXAS vs PVH: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is OXM or GH or RL or EXAS or PVH a better buy right now?

For growth investors, Guardant Health, Inc.

(GH) is the stronger pick with 32. 9% revenue growth year-over-year, versus -6. 1% for PVH Corp. (PVH). Oxford Industries, Inc. (OXM) offers the better valuation at 7. 7x trailing P/E (20. 4x forward), making it the more compelling value choice. Analysts rate Oxford Industries, Inc. (OXM) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — OXM or GH or RL or EXAS or PVH?

On trailing P/E, Oxford Industries, Inc.

(OXM) is the cheapest at 7. 7x versus Ralph Lauren Corporation at 30. 5x. On forward P/E, PVH Corp. is actually cheaper at 8. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: PVH Corp. wins at 0. 60x versus Oxford Industries, Inc. 's 2. 64x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — OXM or GH or RL or EXAS or PVH?

Over the past 5 years, Ralph Lauren Corporation (RL) delivered a total return of +164.

4%, compared to -39. 3% for Oxford Industries, Inc. (OXM). Over 10 years, the gap is even starker: EXAS returned +1669% versus PVH's -1. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — OXM or GH or RL or EXAS or PVH?

By beta (market sensitivity over 5 years), Exact Sciences Corporation (EXAS) is the lower-risk stock at 0.

05β versus Oxford Industries, Inc. 's 1. 74β — meaning OXM is approximately 3207% more volatile than EXAS relative to the S&P 500. On balance sheet safety, PVH Corp. (PVH) carries a lower debt/equity ratio of 66% versus 105% for Exact Sciences Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — OXM or GH or RL or EXAS or PVH?

By revenue growth (latest reported year), Guardant Health, Inc.

(GH) is pulling ahead at 32. 9% versus -6. 1% for PVH Corp. (PVH). On earnings-per-share growth, the picture is similar: Exact Sciences Corporation grew EPS 80. 3% year-over-year, compared to -1. 9% for PVH Corp.. Over a 3-year CAGR, GH leads at 29. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — OXM or GH or RL or EXAS or PVH?

Ralph Lauren Corporation (RL) is the more profitable company, earning 10.

5% net margin versus -42. 4% for Guardant Health, Inc. — meaning it keeps 10. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RL leads at 13. 2% versus -44. 4% for GH. At the gross margin level — before operating expenses — EXAS leads at 69. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is OXM or GH or RL or EXAS or PVH more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, PVH Corp. (PVH) is the more undervalued stock at a PEG of 0. 60x versus Oxford Industries, Inc. 's 2. 64x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, PVH Corp. (PVH) trades at 8. 2x forward P/E versus 582. 8x for Exact Sciences Corporation — 574. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GH: 44. 3% to $133. 14.

08

Which pays a better dividend — OXM or GH or RL or EXAS or PVH?

In this comparison, OXM (6.

0% yield), RL (0. 9% yield), PVH (0. 2% yield) pay a dividend. GH, EXAS do not pay a meaningful dividend and should not be held primarily for income.

09

Is OXM or GH or RL or EXAS or PVH better for a retirement portfolio?

For long-horizon retirement investors, Exact Sciences Corporation (EXAS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

05), +1669% 10Y return). Both have compounded well over 10 years (EXAS: +1669%, PVH: -1. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between OXM and GH and RL and EXAS and PVH?

These companies operate in different sectors (OXM (Consumer Cyclical) and GH (Healthcare) and RL (Consumer Cyclical) and EXAS (Healthcare) and PVH (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: OXM is a small-cap deep-value stock; GH is a mid-cap high-growth stock; RL is a mid-cap quality compounder stock; EXAS is a mid-cap high-growth stock; PVH is a small-cap deep-value stock. OXM, RL pay a dividend while GH, EXAS, PVH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

OXM

Income & Dividend Stock

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Gross Margin > 37%
  • Dividend Yield > 2.4%
Run This Screen
Stocks Like

GH

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 24%
  • Gross Margin > 38%
Run This Screen
Stocks Like

RL

Stable Dividend Mega-Cap

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Net Margin > 7%
Run This Screen
Stocks Like

EXAS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Gross Margin > 41%
Run This Screen
Stocks Like

PVH

Quality Business

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform OXM and GH and RL and EXAS and PVH on the metrics below

Revenue Growth>
%
(OXM: -0.2% · GH: 48.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.